Risk Mitigation News
Most Popular Risk Mitigation Story
Guidance formats risk/benefit measure
The FDA last week issued its first guidance for industry on Risk Evaluation and Mitigation Strategies (REMS), which the regulator can require in cases where it wants to make sure that a drug's Read more...
Latest Headlines
- October 13, 2009
- October 6, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
